Vigil Neuroscience Statistics
Total Valuation
VIGL has a market cap or net worth of $153.44 million. The enterprise value is $80.17 million.
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024, before market open.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VIGL has 39.65 million shares outstanding. The number of shares has increased by 6.00% in one year.
| Shares Outstanding | 39.65M |
| Shares Change (YoY) | +6.00% |
| Shares Change (QoQ) | +1.76% |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 41.36% |
| Float | 20.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.71 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.39, with a Debt / Equity ratio of 0.16.
| Current Ratio | 8.39 |
| Quick Ratio | 8.11 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -70.12% and return on invested capital (ROIC) is -42.21%.
| Return on Equity (ROE) | -70.12% |
| Return on Assets (ROA) | -39.66% |
| Return on Capital (ROIC) | -42.21% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.22M |
| Employee Count | 69 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.75% in the last 52 weeks. The beta is 1.93, so VIGL's price volatility has been higher than the market average.
| Beta (5Y) | 1.93 |
| 52-Week Price Change | -43.75% |
| 50-Day Moving Average | 3.56 |
| 200-Day Moving Average | 3.46 |
| Relative Strength Index (RSI) | 57.80 |
| Average Volume (20 Days) | 100,478 |
Short Selling Information
The latest short interest is 513,298, so 1.29% of the outstanding shares have been sold short.
| Short Interest | 513,298 |
| Short Previous Month | 526,549 |
| Short % of Shares Out | 1.29% |
| Short % of Float | 2.45% |
| Short Ratio (days to cover) | 5.31 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -90.07M |
| Pretax Income | -82.78M |
| Net Income | -83.84M |
| EBITDA | -89.62M |
| EBIT | -90.07M |
| Earnings Per Share (EPS) | -$2.12 |
Full Income StatementBalance Sheet
The company has $86.67 million in cash and $13.41 million in debt, giving a net cash position of $73.27 million or $1.85 per share.
| Cash & Cash Equivalents | 86.67M |
| Total Debt | 13.41M |
| Net Cash | 73.27M |
| Net Cash Per Share | $1.85 |
| Equity (Book Value) | 85.27M |
| Book Value Per Share | 2.27 |
| Working Capital | 79.46M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$70.21 million and capital expenditures -$65,000, giving a free cash flow of -$70.27 million.
| Operating Cash Flow | -70.21M |
| Capital Expenditures | -65,000 |
| Free Cash Flow | -70.27M |
| FCF Per Share | -$1.77 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |